Testosterone Replacement Monitoring & Management Kent

Juvenology Clinic
Apr 8
14 min read

One of the most common conversations I have at Juvenology doesn't involve aesthetics at all. It involves a man in his 40s or 50s who is on testosterone replacement therapy. Some through a private clinic. Some through their GP. Increasingly, some through an online prescription service. And most of them haven't had a comprehensive blood panel in months.

Sometimes they have never had one beyond the initial testosterone level that got them prescribed.

That gap matters enormously. TRT is not a supplement. It is a medical intervention that creates measurable physiological changes throughout the body, in your blood cell count, your cardiovascular markers, your liver function, your prostate, your bone density, and your skin. Each of those systems needs to be looked at regularly. Not once at the start and then quietly forgotten as the prescription renews.

Bearded man looks focused in a gym setting. Warm lighting highlights his expression. Blurred gym equipment in the background. No text visible.

I am writing this because the information gap is real, because the consequences of inadequate monitoring are real, and because at Juvenology we run a comprehensive blood panel service specifically designed to give men on TRT the full clinical picture their prescribers should be tracking. This post is for men who are on TRT, men who are considering it, and men who want to understand what responsible long-term management of this therapy actually looks like.

What TRT is actually doing to your body

Testosterone does not work in isolation. It is converted, metabolised, and interacts with systems throughout the body in ways that go well beyond the symptoms it is prescribed to address, fatigue, low libido, reduced muscle mass, mood changes, cognitive fog.

When you add exogenous testosterone, your body responds in several ways simultaneously. Your red blood cell production increases. Your oestradiol levels may rise as testosterone is converted to oestrogen by the aromatase enzyme, particularly in fat tissue. Your natural testosterone production is suppressed, because the brain detects sufficient testosterone and stops signalling the testes to make more. Your PSA may rise modestly. Your lipid profile may shift. Your haematocrit, the proportion of your blood volume occupied by red blood cells, climbs.

All of this is manageable. None of it is a reason to avoid TRT if you are genuinely deficient and symptomatic. But all of it needs to be watched. The difference between TRT that is safe and effective long-term and TRT that creates problems is almost entirely a question of monitoring quality and frequency. That distinction is what this article is about.

What UK guidelines say

The British Society for Sexual Medicine is the leading UK authority on testosterone deficiency and treatment. Its guidelines are clear: blood tests before starting TRT, then at 3, 6, and 12 months, and annually thereafter once levels are stable. The European Expert Panel on Testosterone Research, reviewing the landmark TRAVERSE trial data in 2025, aligned with this schedule and added specific timing guidance depending on whether you are using gels, injections, or long-acting formulations.

What many men don't realise is that the monitoring isn't just about checking whether your testosterone level is in range. That is actually the smallest part of it. The markers that carry the most significant safety implications are haematocrit, PSA, and oestradiol, and these are often the ones that fall through the gaps in online and GP-led TRT care. Let me go through each one properly.

The markers that actually matter

Total and free testosterone

The obvious starting point, but not the complete picture. Total testosterone gives you the gross level in the blood, but testosterone binds to a protein called sex hormone-binding globulin, SHBG, that renders it biologically inactive. The fraction not bound to SHBG, free testosterone, is what your tissues actually use.

The typical target on TRT is 15 to 30 nmol/L for total testosterone, with free testosterone in the upper part of the reference range. Consistently below 15 suggests underdosing. Consistently above 30 raises the side-effect risk profile. The timing of the test relative to your last dose matters enormously. For injectable testosterone such as Sustanon or Nebido, the BSSM recommends testing at trough, just before your next injection, to get the lowest point in your cycle. For gels, test approximately 2 to 4 hours after application.

SHBG

SHBG is what binds testosterone and takes it out of circulation. High SHBG means less free testosterone available to your tissues despite an apparently normal total level, which is why some men remain symptomatic even with total testosterone within the reference range. Low SHBG, associated with obesity, insulin resistance, and high-dose TRT, means more free testosterone but also faster metabolism of the hormone and greater conversion to oestradiol. Understanding your SHBG level is what allows your prescriber to make sense of your total and free testosterone readings together and to dose and time your TRT appropriately.

Haematocrit and full blood count

This is the one I want men to understand most clearly, because it carries the most immediate safety implications and is the most commonly under-monitored marker in TRT care.

Testosterone stimulates the kidneys to produce erythropoietin, which signals the bone marrow to produce more red blood cells. This effect is dose and concentration dependent and is more pronounced with injectable testosterone, particularly Sustanon and other short-acting injectables that produce high peaks after injection, than with gels, which provide more stable levels.

As haematocrit rises, the blood becomes more viscous. A haematocrit above 54% is the widely accepted threshold requiring intervention, and is the level at which the BSSM, the Endocrine Society, and the European Association of Urology all recommend action: dose reduction, switching formulation, or therapeutic phlebotomy, which is medically supervised blood removal. Research published in the Journal of Urology found that developing polycythaemia on TRT independently increases the risk of venous thromboembolism and major cardiovascular events, particularly in the first year of therapy.

The risk factors that make haematocrit more likely to rise on TRT are injectable testosterone, older age, smoking, untreated sleep apnoea, obesity, and living at altitude. Men with any of these risk factors need more frequent haematocrit monitoring, every 3 months in the first year rather than every 6.

The TRAVERSE trial, the largest randomised controlled trial of testosterone therapy ever conducted with 5,246 participants, provided important evidence on cardiovascular safety and confirmed that TRT does not increase overall risk of major adverse cardiac events. It did however identify higher incidences of atrial fibrillation and pulmonary embolism in the testosterone group. Haematocrit monitoring is part of how these risks are managed, not an optional extra.

In six years of cardiac nursing I watched what happens when elevated viscosity goes undetected for months. The haematocrit that nobody caught is one of the most preventable risks in TRT management. It is also one of the most commonly missed.

PSA

PSA monitoring on TRT is essential and frequently misunderstood. Current evidence, including the TRAVERSE trial and the 2023 BSSM guidelines, does not support the historical belief that TRT causes prostate cancer. The prostate cancer rates in the TRAVERSE trial were essentially identical in the testosterone and placebo groups.

What TRT does do is stimulate existing prostate tissue, causing a modest predictable rise in PSA, typically 0.3 to 0.5 ng/mL in the first year, which then plateaus. This is expected and is not itself a cause for concern. What does require investigation is a PSA rise of more than 1.4 ng/mL within 12 months of starting TRT, or an absolute PSA level exceeding 4.0 ng/mL in men over 50. These thresholds should prompt urology referral.

The practical implication is straightforward: a baseline PSA before you start TRT is not optional. Without it, any subsequent rise has no context. You cannot determine whether a level is concerning or expected without knowing where you started.

Oestradiol

Testosterone is converted to oestradiol by the aromatase enzyme, which is concentrated in adipose tissue. This conversion is a normal part of male physiology. Men need oestrogen for bone density, cardiovascular health, and even sexual function. The problem arises when oestradiol rises too high, which is more likely in men with higher body fat, on higher TRT doses, or using injectable testosterone that produces high peaks.

Elevated oestradiol in men on TRT produces a recognisable symptom cluster: gynaecomastia, water retention, emotional lability, reduced libido despite adequate testosterone, fatigue, and, particularly relevant for Juvenology patients, skin oiliness and acne. The target range for oestradiol in men on TRT is broadly 80 to 150 pmol/L, with consistent levels above 200 pmol/L warranting discussion about dose or formulation adjustment.

Aromatase inhibitors, which block the conversion of testosterone to oestradiol, are sometimes used to manage high oestradiol on TRT. Their use is increasingly controversial. Research referenced in an FDA submission in 2025 noted that aromatase inhibitors in men worsen lipid profiles, increase cardiovascular risk, and accelerate bone loss. They should be used cautiously and under specialist supervision, not as a routine protocol step, and I would want any man considering them to understand this evidence before agreeing to them.

Lipid profile

TRT can alter the lipid profile, most notably by reducing HDL cholesterol, the protective fraction, and in some studies modestly increasing LDL. The clinical significance of these changes depends on baseline cardiovascular risk and other factors including diet, exercise, and metabolic health. Lipid monitoring at 3 and 6 months after starting TRT, and annually thereafter, allows early identification of adverse trends.

Liver function

Modern injectable and gel testosterone formulations carry significantly less hepatotoxicity risk than the oral preparations used historically. Nevertheless, periodic liver function testing remains part of the standard monitoring protocol, both as a safety check and because liver function influences SHBG production and therefore the free testosterone picture.

HbA1c and fasting glucose

Men with low testosterone are at significantly higher risk of insulin resistance and type 2 diabetes. The BSSM notes that TRT in men with pre-diabetes and testosterone levels of 14 nmol/L or below has been shown to reduce progression to type 2 diabetes by 40% over two years, a striking metabolic benefit that extends well beyond sexual function and body composition. Monitoring HbA1c and fasting glucose as part of a comprehensive TRT panel gives you the metabolic picture alongside the hormonal one and allows early intervention if insulin sensitivity is deteriorating despite treatment.

Bone density

Low testosterone is strongly associated with reduced bone mineral density and increased fracture risk. TRT has been shown to improve bone density in hypogonadal men and the TRAVERSE trial confirmed this benefit with fracture data. For men who start TRT with established bone density concerns, or those who have been on it for several years without a DEXA scan, baseline and follow-up bone density assessment provides important long-term context.

What TRT does to your skin

This is where the longevity medicine and aesthetic medicine perspectives meet, and where Juvenology occupies a genuinely different clinical position from a standard TRT monitoring service.

Men on TRT frequently experience skin changes that they don't connect to the therapy. Understanding them helps you manage them and in some cases helps your prescriber adjust your protocol.

Oiliness and acne are the most common skin-related side effects of TRT. Testosterone stimulates sebaceous glands and elevated androgen levels, including from supraphysiological testosterone peaks from injectables, increase sebum production. This is amplified when oestradiol is also elevated. Men who experience significant skin oiliness or new-onset acne on TRT should have their oestradiol and haematocrit checked before assuming a topical skincare fix is the answer. Often a dosing or formulation adjustment resolves the issue at source. Treating the surface symptom without understanding the driver is the aesthetic medicine equivalent of prescribing antacids without identifying the underlying cause.

Skin thickness and collagen. As we covered in the testosterone and skin article, testosterone supports dermal thickness and collagen production by activating fibroblasts. Men who achieve and maintain optimal testosterone levels on TRT often notice improvements in skin density and texture over time. The converse is also true: men who are inadequately dosed, or whose levels fluctuate significantly due to injection timing, may experience ongoing skin laxity and reduced regenerative capacity. Stable, consistent testosterone levels, which gels tend to produce more reliably than injectables for some men, can produce better skin outcomes than protocols with large peaks and troughs.

Hair. TRT's relationship with hair is complex. Testosterone does not directly cause male pattern baldness, but its conversion to DHT via 5-alpha reductase accelerates hair follicle miniaturisation in genetically susceptible men. Conversely, testosterone replacement in genuinely deficient men has in some studies supported hair regrowth in areas affected by telogen effluvium related to the deficiency itself. If hair thinning is a concern on TRT, DHT level and genetic susceptibility are the relevant variables. Our PRP scalp treatment can support follicular health in men experiencing TRT-related thinning.

Shirtless man with short hair does shoulder exercises with a yellow bar in a green park. He appears focused, with trees blurred in the background.

Why many men on TRT in the UK are under-monitored

NHS TRT access is limited and often involves strict diagnostic thresholds. The NHS typically requires total testosterone below 8.6 nmol/L for treatment combined with clear symptoms, and the monitoring once established, while adequate by minimum standard guidelines, is usually annual at best, covering testosterone level, full blood count, liver function, and PSA. The nuanced markers, free testosterone, SHBG, oestradiol, lipids, HbA1c, are rarely included.

Private TRT clinics vary enormously. Some run comprehensive initial panels and rigorous follow-up. Others provide testosterone prescriptions with minimal ongoing oversight, driven by commercial pressure rather than clinical best practice. Online services are particularly variable.

The result is a significant cohort of men on TRT who are feeling better than they did before treatment but who are not being monitored comprehensively enough to catch the markers that could cause problems over time. A haematocrit creeping upward for six months without anyone noticing. A PSA that has risen 1.8 ng/mL from baseline with no urology referral triggered. An oestradiol that explains why libido has dropped despite adequate testosterone. These are not rare clinical scenarios. They are what inadequate monitoring produces.

What a comprehensive TRT blood panel looks like at Juvenology

Man in a gray tank top holds black ropes, standing in a wooden and concrete room. He appears strong and confident, with a slight smile.

Our Advanced Blood Panel is designed to provide the complete monitoring picture that TRT requires, interpreted in the context of how you feel and how you are responding to treatment, not just a list of numbers compared against a reference range.

The core markers we include for men on TRT: total testosterone and free testosterone, SHBG, oestradiol, LH and FSH, haematocrit and full blood count, PSA, lipid profile, liver function, kidney function, HbA1c and fasting glucose, and thyroid function.

We time the blood draw appropriately to your formulation, trough for injectables, mid-cycle for gels, because the timing of the test is as clinically important as the test itself. We review results in the context of your symptoms, your TRT protocol, and your wider health picture, and provide clear guidance on what they mean and whether anything needs to change.

For men also experiencing skin changes, acne, oiliness, laxity, hair thinning, the panel gives us the hormonal context that allows us to address those concerns properly rather than treating the surface symptom without understanding the driver. Where regenerative skin treatments are appropriate, we can integrate these with your TRT monitoring in a single Juvenology appointment.

When to test: timing by formulation

This is one of the most practically important and most poorly communicated aspects of TRT monitoring.

Sustanon (mixed testosterone esters, typically injected every 3 to 4 weeks): test at trough, immediately before your next injection. This gives the lowest point in your cycle and the most conservative safety read on haematocrit.

Nebido (testosterone undecanoate, long-acting depot injection every 10 to 14 weeks): test approximately one week before your next scheduled injection.

Testosterone gels: test 2 to 4 hours after application, avoiding the application site for the blood draw.

All formulations: the first-year schedule should be baseline, then 3 months, 6 months, and 12 months. Once stable, annually. And annual means annually, not whenever the patient remembers to book.

A note on fertility

This is outside the scope of the blood panel conversation but matters enough to mention. TRT suppresses the hypothalamic-pituitary-gonadal axis, which reduces or eliminates sperm production. Men who are on TRT and want to preserve future fertility should discuss this with their prescriber before starting and should not rely on TRT as a form of contraception. LH and FSH monitoring gives some indication of whether endogenous production is being suppressed.

Book your TRT blood panel at Juvenology, Maidstone

If you are on TRT in Kent and your monitoring has been inconsistent, incomplete, or too infrequent, or if you simply want a comprehensive clinical review of where you stand, that is exactly what the Juvenology blood panel service is for.

Book your comprehensive blood panel at Juvenology

In 25 years of nursing, first in cardiology and now in longevity medicine, I have worked with men whose cardiovascular complications were attributable at least in part to inadequate monitoring of a treatment they were taking in good faith. The haematocrit that nobody caught. The PSA rise that wasn't acted on. These are preventable. Comprehensive, timely blood monitoring is not the administrative part of TRT. It is the clinical foundation on which everything else rests.

We see men on TRT from across Kent including Maidstone, Tonbridge, Sevenoaks, Kings Hill, West Malling, Medway, and Chatham.

About the author

Woman in a white dress and glasses sits on a black stool against a plain white background, smiling confidently with hand near face.

Nurse Marina is an aesthetic nurse specialist and longevity medicine practitioner based in Maidstone, Kent, with over 25 years of nursing experience including cardiac care at KIMS Hospital. She holds an EMSc in Longevity from the Geneva College of Longevity Science, a Longevity Medicine Intensive from NUS Yong Loo Lin School of Medicine in Singapore, and a qualification in Hormonal Health and Bioidentical Hormone Therapy from the Marion Gluck Academy. Marina is NMC Registered, JCCP Verified, BACN Member, ACE Group Registered, and a Member of the Royal College of Nursing.

From anti-wrinkle injections and dermal fillers to advanced regenerative treatments and longevity medicine, Marina combines rigorous medical knowledge with a nurturing, patient-centred approach.

Book a Consultation with Nurse Marina

Here are ready-to-use internal linking sections for the TRT monitoring article, written in Marina's voice and designed to sit naturally within the page.

Related services at Juvenology

The blood panel is often the starting point of a broader conversation about how your body is ageing and what can be done about it. These are the services most relevant to men on TRT.

Advanced Blood Panel Our comprehensive blood testing service includes every marker covered in this article, timed correctly to your TRT formulation and interpreted in full clinical context rather than just compared against a reference range.

Longevity Medicine For men who want to go beyond monitoring and address the full biological picture, our longevity medicine consultations integrate hormonal health, inflammatory markers, metabolic health, and regenerative treatment into a single joined-up protocol.

PRP Injections For men experiencing TRT-related hair thinning, PRP scalp treatment supports follicular health and accelerates recovery. Particularly effective when hair loss is driven by DHT sensitivity or telogen effluvium related to hormonal fluctuation.

Red Light Therapy Supports mitochondrial function and reduces systemic inflammation between appointments. Used as part of a broader longevity protocol for men whose inflammatory markers are elevated alongside hormonal changes.

Polynucleotides For men on TRT experiencing skin laxity or reduced regenerative capacity, polynucleotide treatment stimulates fibroblast activity at the tissue level and works directly with the skin biology that testosterone is influencing.

Explore the Juvenology blog

The articles below are the most relevant starting points for men thinking about hormonal health, skin ageing, and longevity medicine.

Topic	Article
Why skin changes as testosterone declines	Testosterone and Skin Health
The science of biological ageing	What Is Longevity Medicine?
Chronic inflammation and ageing	Inflammaging
Cortisol, stress and skin	Cortisol and Skin Ageing
Cellular energy and fatigue	NAD+ Therapy
Measuring your biological age	Biological Age Testing
B12, energy and recovery	Vitamin B12 Injections
Regenerative skin treatments	Regenerative Aesthetics Guide

Not sure where to start?

If you have read this far and are unsure whether your current TRT monitoring is complete, the most useful next step is a consultation at Juvenology. We will review your existing blood results, identify any gaps in your monitoring, and give you a clear picture of where you stand before recommending anything.